Prime Therapeutics Rolls Out New Real Time Benefit Tool

With the deadline approaching for Medicare Part D plans to implement a Real Time Benefit Tool (RTBT) — which informs prescribers when lower-cost alternative therapies are available under a beneficiary’s drug benefit — one PBM is offering up a new tool to fulfill the requirement.

Prime Therapeutics, LLC, a PBM collectively owned by 18 Blue Cross and Blue Shield plans, said on Sept. 2 that it is rolling out a tool called Real Time Benefit Check, which works through the ePrescribe function of a health care provider’s electronic health record (EHR) system. The idea is to offer providers “comprehensive information so they can easily prescribe the most appropriate and cost-effective medications at the point of care,” per a news release from the PBM.

© 2022 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

workers-prepping-infusion-drug
May 12

Major PBMs Look Ahead to 2023 for Biosimilars Boom

READ MORE
wall-street-sign
May 12

Centene Plans to Sell Magellan Rx, PANTHERx Rare for $2.8 Billion

READ MORE
pills-and-dollars
May 12

Study: With High Prices, Rebate Revenue Is Growing for PBMs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today